1. Meaning 

Biotechnology Criminal Governance refers to the legal and institutional framework through which governments regulate, prevent, investigate, and punish criminal conduct involving biotechnology. It covers the misuse of genetic engineering, gene editing, biological materials, biotechnology products, genetic information, and biological research.

The subject combines criminal law, public health law, biosecurity, environmental protection, constitutional rights, research ethics, and corporate accountability.

Examples of conduct that may raise criminal-governance issues include:

Deliberate unauthorized release of genetically modified organisms (GMOs) that creates serious risks to human health or the environment.

Theft, unlawful possession, or deliberate misuse of biological samples.

Fraud involving genetic tests, biotechnology medicines, or clinical-trial results.

Unauthorized access to genetic databases or unlawful disclosure of protected genetic information, where criminal statutes apply.

Deliberate misuse of biological agents for criminal or terrorist purposes.

Falsification of laboratory records, concealment of dangerous side effects, or intentional obstruction of regulatory inspections.

An important distinction is that not every biotechnology violation is a crime. Some breaches attract administrative penalties, civil liability, licence suspension, or regulatory corrective measures. Criminal punishment ordinarily requires a specific offence and proof of its legal elements.

2. Objectives of biotechnology criminal governance

The principal objectives are:

Public safety: Prevent criminal conduct that threatens human health, food safety, or the environment.

Biosecurity: Reduce the risk of deliberate misuse of biological materials and biotechnology.

Research integrity: Deter fraud, fabricated results, and unlawful clinical experimentation.

Protection of individual rights: Safeguard informed consent, bodily autonomy, genetic privacy, and dignity.

Corporate accountability: Establish responsibility where companies or responsible officers commit offences or knowingly facilitate unlawful conduct.

Proportionate enforcement: Ensure that investigation and punishment comply with legality, due process, and the presumption of innocence.

A sound system must balance scientific freedom and beneficial innovation against genuine risks of criminal misuse.

3. Legal framework in India

India does not have one comprehensive statute titled “Biotechnology Criminal Governance.” Instead, the relevant rules are distributed across environmental, criminal, medical, pharmaceutical, food-safety, and data-protection laws.

A. Environment (Protection) Act, 1986

The Act is a major foundation for controlling risks arising from hazardous microorganisms and genetically engineered organisms.

Relevant provisions include:

Section 5: Empowers the Central Government to issue directions within the scope of the Act.

Section 15: Provides for punishment for contraventions, subject to the applicable statutory version and amendments.

Section 16: Addresses offences by companies and the responsibility of relevant officers.

Section 17: Addresses offences by government departments.

The 1989 Rules governing hazardous microorganisms and genetically engineered organisms regulate matters such as manufacture, import, storage, research, use, and environmental release. Rule 7 addresses approvals and restrictions, while Rules 8–12 deal with production, release, and approvals.

IndiaCode+2

Legal significance: A person or organization that breaches a legally applicable restriction may face regulatory action and, where the statutory requirements are satisfied, criminal proceedings. The precise offence, penalty, and procedure must be assessed under the law in force when the alleged conduct occurred.

B. Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994

The PC-PNDT Act regulates genetic and prenatal diagnostic facilities and prohibits sex selection.

Important provisions include:

Sections 3A and 3B: Prohibit sex selection and restrict the sale of specified diagnostic equipment to unregistered facilities.

Sections 4–6: Regulate prenatal diagnostic techniques and prohibit prenatal sex determination.

Section 23: Prescribes offences and penalties for specified violations.

Section 26: Deals with offences by companies.

Section 23 provides for imprisonment and fines for covered violations. The penalties differ depending on the accused, the offence, and whether it is a subsequent conviction.

IndiaCode+2

Example: A genetic clinic that unlawfully conducts fetal sex determination may face criminal prosecution under the Act. This is a direct example of criminal governance involving genetic technology.

C. Bharatiya Nyaya Sanhita, 2023 (BNS)

The BNS, which came into force on 1 July 2024, may apply when biotechnology-related conduct also constitutes an ordinary criminal offence.

Depending on the facts and statutory elements, relevant offences might involve:

Causing death or bodily injury.

Criminal conspiracy or abetment.

Forgery or falsification of records.

Cheating and fraud.

Criminal intimidation or destruction of evidence.

The BNS does not create a general offence covering every misuse of biotechnology. Prosecutors must identify the applicable offence and establish its elements. Conduct predating 1 July 2024 must also be assessed under the applicable temporal rules and savings provisions.

D. Drugs and Cosmetics Act, 1940, and associated rules

Biotechnology-derived medicines, vaccines, and certain biological products may be subject to pharmaceutical regulation.

Depending on the circumstances, manufacturing or marketing a product in breach of applicable legal requirements, falsifying relevant records, or distributing adulterated or misbranded products may attract regulatory or criminal consequences.

Example: Knowingly falsifying clinical-trial records or manufacturing a biological medicine in violation of an applicable statutory prohibition may trigger prosecution where the relevant offence is established.

E. Food Safety and Standards Act, 2006

This Act is relevant to food products involving biotechnology, including applicable genetically modified food requirements.

Section 23 concerns packaging and labelling, while other provisions regulate food safety, unsafe food, and related offences. The legal consequences depend on the specific conduct and the applicable statutory provisions.

VoxJuris+1

F. Biological Diversity Act, 2002

This Act regulates specified activities involving biological resources and associated knowledge, including certain access and benefit-sharing obligations. It may become relevant where biotechnology research involves biological resources obtained or used contrary to applicable legal requirements.

Not every breach of biodiversity regulation is automatically a criminal offence; the applicable provision and current penalty regime must be checked.

4. Institutional structure of criminal governance

India's biotechnology governance system involves several authorities with different responsibilities.

Institutional Biosafety Committee (IBSC)

Reviews biosafety issues within research institutions and helps oversee compliance with applicable research and containment requirements.

Review Committee on Genetic Manipulation (RCGM)

Reviews and monitors relevant research activities involving genetically engineered organisms and hazardous microorganisms.

Genetic Engineering Appraisal Committee (GEAC)

Performs the relevant environmental appraisal and approval functions for regulated activities, including specified environmental releases.

Police, prosecutors, and courts

Investigate suspected criminal offences, assess evidence, conduct prosecutions, and determine guilt and punishment under the applicable law.

These roles derive from India's biosafety framework, particularly the 1989 Rules and the associated regulatory arrangements. Regulatory approval and criminal adjudication are separate functions: an administrative committee does not, merely by identifying a violation, establish criminal guilt.

IBKP+2

5. Important case laws

The following decisions are relevant to biotechnology criminal governance. Some concern direct criminal enforcement of genetic technologies; others concern biosafety regulation, constitutional safeguards, or the principles governing liability.

Case 1: Gene Campaign v. Union of India — GMO regulation and judicial review

Supreme Court of India · 2024 · GMO governance

Legal issue: Whether governmental decisions concerning genetically modified crops are subject to judicial review and whether India's regulatory framework adequately addresses environmental and public-interest concerns.

Decision and significance: In the 2024 proceedings concerning genetically modified crops, the Supreme Court addressed regulatory oversight, the need for a national policy on GM crops, and concerns involving environmental safety and public participation. The judgment also dealt with the regulatory decision concerning genetically modified mustard, with differences between the judges on aspects of the case.

Manupatra eNewsLine+1

Principle for criminal governance:

Regulatory authorities must act within the law and consider relevant scientific and environmental evidence.

Judicial review can scrutinize the legality of regulatory decisions.

Inadequate regulatory compliance may warrant administrative or judicial intervention, although it does not automatically establish a criminal offence.

This is principally a regulatory and constitutional case, not a conviction for biotechnology-related criminal conduct.

Case 2: Ravinder Kumar v. State of Haryana — 2024 INSC 684

Supreme Court of India · Criminal Appeal No. 3747 of 2024 · Judgment dated 12 September 2024

Legal issue: The legality of proceedings involving alleged unlawful prenatal sex determination, including the statutory requirements governing searches and seizures.

The case concerned allegations of illegal sex determination using ultrasound equipment. The appellant challenged the complaint and FIR, raising objections concerning the authorization of the search.

Sci API

Legal significance:

Section 30 of the PC-PNDT Act governs statutory search-and-seizure powers.

The statutory requirements governing authorization and the powers of the appropriate authority matter in criminal proceedings.

Allegations must be examined through lawful procedures; the seriousness of an alleged offence does not eliminate procedural safeguards.

The judgment is useful for understanding the intersection of genetic diagnostic technology, specialized regulatory legislation, and criminal procedure. It should not be cited as establishing that every procedural defect necessarily invalidates a prosecution; the Court's actual holdings and the facts must be examined.

Case 3: Federation of Obstetrics and Gynaecological Societies of India (FOGSI) v. Union of India

Supreme Court of India · 2019 · PC-PNDT enforcement

Legal issue: Implementation and enforcement of the PC-PNDT framework governing prenatal diagnostic techniques and sex selection.

Importance: The litigation addressed regulatory obligations affecting medical professionals, clinics, and the use of diagnostic technologies. It illustrates why recordkeeping, registration, oversight, and compliance procedures are important when diagnostic technology can be misused.

VoxJuris+1

Application: In biotechnology governance, regulatory controls must be backed by effective enforcement, but criminal liability still depends on the particular statutory offence, evidence, and applicable procedural requirements.

Case 4: Monsanto Co. v. Geertson Seed Farms, 561 U.S. 139 (2010)

Supreme Court of the United States · 2010 · Environmental regulation

Legal issue: Whether broad injunctive relief was justified in litigation concerning the deregulation of genetically engineered alfalfa without a sufficient environmental review.

Decision: The US Supreme Court reversed the lower court's broad injunction and remanded the matter, holding that the injunction was not justified on the record before it. The dispute arose under US environmental law, rather than a criminal prosecution.

Legal Information Institute

Relevance: The case illustrates that courts can review regulatory decisions involving genetically engineered organisms and that remedies must be supported by the applicable legal standards and evidence.

Its value for criminal governance is indirect: it helps explain the distinction between environmental regulatory disputes and criminal liability.

Case 5: Common Cause v. Union of India — genetic diagnostic governance and enforcement context

For legal writing, a more directly relevant line of authority is the Supreme Court's PC-PNDT jurisprudence, including FOGSI v. Union of India and the criminal appeal in Ravinder Kumar v. State of Haryana.

These authorities show that biotechnology-related enforcement can involve both substantive prohibitions and procedural safeguards. The exact case and paragraph should be verified before attributing a particular holding to Common Cause; it is not necessary to rely on that case for the central propositions discussed here.

6. Constitutional principles governing biotechnology crimes

Article 14: Equality before the law

Biotechnology laws and their enforcement must operate consistently with equality and non-arbitrariness. Regulatory authorities should not selectively prosecute similarly situated laboratories or companies without a legally defensible basis.

Article 21: Life, health, and personal liberty

Article 21 is relevant to the protection of life, bodily integrity, privacy, and a healthy environment. These interests may support appropriate safeguards against serious biotechnology risks.

However, constitutional rights do not independently create a criminal offence whenever a biotechnology activity is harmful. Criminal punishment requires a valid legal basis.

Article 19(1)(g): Freedom of profession and business

Biotechnology companies and researchers may invoke the right to practise a profession or conduct business, subject to reasonable restrictions under Article 19(6). Licensing, biosafety requirements, and proportionate regulatory controls may be justified to protect public health and the environment.

Article 20: Protection in criminal proceedings

Article 20 protects against, among other things, retrospective criminal punishment and double jeopardy, and protects against compelled self-incrimination within its constitutional scope.

These safeguards are particularly important when scientific records, laboratory evidence, and corporate documents are collected during an investigation.

Article 22 and due process

Arrest, detention, and criminal proceedings must comply with applicable constitutional and statutory safeguards. The need to protect public health does not justify arbitrary coercion.

7. Corporate criminal liability in biotechnology

Biotechnology research and manufacturing frequently involve companies, laboratories, hospitals, universities, and research partnerships. A central question is when an organization, its directors, or its employees can be held legally responsible.

A. Liability of the company

A company may face prosecution where an applicable statute makes its conduct an offence. Depending on the statute and offence, liability may arise from conduct attributable to the company, including acts performed through responsible personnel.

B. Liability of directors and officers

A director is not automatically criminally liable merely because they hold office in a biotechnology company. The prosecution must establish the applicable statutory basis for personal liability.

Relevant factors may include:

Whether the officer was responsible for the conduct in question.

Whether the officer authorized or knowingly facilitated the prohibited activity.

Whether the applicable statute expressly provides for liability based on consent, connivance, neglect, or another specified ground.

Whether the evidence establishes the required mental element, where applicable.

C. Negligence and deliberate misconduct

The law must distinguish between an accidental biosafety failure, negligence, reckless conduct, and deliberate criminal misuse. The classification determines which legal provisions may apply and what must be proved.

A laboratory accident, for example, does not automatically establish criminal guilt. However, a serious incident involving intentional concealment, falsified safety records, or knowing disregard of a legally enforceable prohibition may warrant more serious legal scrutiny.

8. International governance and comparative law

Biotechnology criminal governance also has an international dimension.

India's biosafety framework references both the Convention on Biological Diversity and the Cartagena Protocol.

IBKP+1

International obligations do not automatically make every prohibited act a domestic criminal offence. Domestic implementation, applicable treaty obligations, and the elements of the relevant offence must be examined.

9. Practical hypothetical examples

Scenario A: Unauthorized environmental release

A company deliberately releases a genetically engineered organism without obtaining an approval required by applicable law.

Legal analysis: Investigators would examine the relevant approval requirements, the 1989 Rules, the nature of the release, and the penalty provisions currently in force. The incident may lead to regulatory orders, penalties, restoration measures, or criminal liability under another applicable offence if its elements are established.

Scenario B: Unlawful prenatal sex determination

A clinic conducts prenatal sex determination in violation of the PC-PNDT Act.

Legal analysis: Sections 4, 5, 6, and 23 may be relevant, depending on the conduct. The prosecution must also comply with the Act's requirements for complaints and authorized searches.

Scenario C: Falsified biotechnology trial data

A manufacturer knowingly falsifies clinical-trial records to conceal serious product risks.

Legal analysis: Investigators would assess the applicable pharmaceutical and clinical-trial rules and whether the conduct constitutes forgery, cheating, or another offence under the relevant criminal law. The specific facts and statutory requirements determine liability.

Scenario D: Negligent containment failure

A research laboratory experiences an accidental release after failures in its containment procedures.

Legal analysis: Authorities would examine the cause of the incident, applicable biosafety obligations, actual or potential harm, corrective action, and the legal basis for any penalty or prosecution. An accident alone does not prove a criminal offence.

10. Major challenges in biotechnology criminal governance

Rapid scientific development: Laws may not keep pace with gene editing, synthetic biology, and new diagnostic methods.

Scientific complexity: Investigators and courts may need independent experts to interpret genetic and laboratory evidence.

Attribution of responsibility: It may be difficult to identify who authorized a decision within a complex research organization.

Cross-border enforcement: Biological materials, digital records, research teams, and supply chains may span several jurisdictions.

Privacy and civil liberties: Investigations must protect legitimate genetic privacy interests and follow lawful evidence-gathering procedures.

Proportionality: Criminal punishment should be reserved for conduct covered by criminal law, while technical or administrative breaches should receive the treatment prescribed by the applicable statute.

Regulatory independence: Scientific assessments should be transparent, evidence-based, and protected against conflicts of interest.

11. Important current-law qualification

India's environmental penalty framework has changed significantly. From 1 April 2024, amendments made by the Jan Vishwas (Amendment of Provisions) Act, 2023 replaced the former general criminal-penalty framework in Sections 14–17 of the Environment (Protection) Act with specified civil penalties and related procedures. Some separate criminal provisions remain, including an offence for failure to pay certain penalties within the prescribed period.

legislations.in+2

Consequently, it would be inaccurate to assume that every breach of the Environment (Protection) Act or the 1989 Rules automatically attracts the former imprisonment provision. For a real incident, the relevant section, applicable amendment, date of conduct, and any continuing or transitional provisions must be checked carefully.

12. Recommendations for an effective governance framework

A robust biotechnology criminal-governance system should include:

Clear statutory definitions of prohibited conduct and associated mental elements.

Risk-based biosafety standards and enforceable licensing conditions.

Independent inspection, credible laboratory evidence, and reliable chain-of-custody procedures.

Protection for whistleblowers who report dangerous or unlawful practices.

Proportionate sanctions, including criminal prosecution for conduct that genuinely meets the statutory threshold.

Effective corporate compliance systems and clearly allocated management responsibilities.

Judicial review, fair hearings, and protection against arbitrary enforcement.

International cooperation for cross-border biological crime investigations.

Conclusion

Biotechnology Criminal Governance is the coordinated application of criminal law, biosafety regulation, constitutional safeguards, and institutional accountability to prevent and respond to unlawful conduct involving biological science.

In India, the principal legal framework includes the Environment (Protection) Act, 1986 and the 1989 Rules, the PC-PNDT Act, pharmaceutical legislation, food-safety law, biodiversity legislation, and the applicable general criminal law. The cases concerning Gene Campaign and Ravinder Kumar illustrate two distinct dimensions: judicial scrutiny of biotechnology regulation and the lawful enforcement of offences involving genetic diagnostic technology.

The central legal principle is that biotechnology risks require effective oversight, but criminal liability must always rest on a valid legal provision, sufficient evidence, and a fair procedure.

For further study, a useful next topic would be “Biotechnology Criminal Accountability Doctrine: Detailed Explanation with Case Laws”, which focuses more specifically on individual, corporate, and institutional responsibility.